Bruker Corporation Introduces the MALDI SepsityperTM Kit for Rapid MALDI Biotyper Microbial Identification from Positive Blood Cultures

BOSTON--(BUSINESS WIRE)--At the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Bruker Daltonics Inc. today announced the introduction of the new MALDI SepsityperTM kit for the rapid identification of microorganisms from positive blood culture bottles, using Bruker’s industry-leading MALDI Biotyper solution. The MALDI Biotyper has obtained the IVD-CE Mark, and is currently for Research Use Only (RUO) outside of the European Union.

MORE ON THIS TOPIC